Investor Relations : Copyright West LLC. Minimum 15 minutes delayed. AST Shareholder Services: www.astfinancial.com/contact-us (800) 937-5449 Press Releases Jan 2, 2019 Summary ToggleDaré Bioscience Provides Update for Investors on Development Programs and Anticipated 2019 Milestones Dec 6, 2018 Summary ToggleDaré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis View all press releases » Events & Presentations More events are coming soon. View all events & presentations »
